{"id":716072,"date":"2024-10-09T12:20:01","date_gmt":"2024-10-09T12:20:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=716072"},"modified":"2024-10-09T12:20:01","modified_gmt":"2024-10-09T12:20:01","slug":"coronary-heart-disease-market-size-epidemiology-industry-trends-and-forecast-20242034","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/coronary-heart-disease-market-size-epidemiology-industry-trends-and-forecast-20242034_716072.html","title":{"rendered":"Coronary Heart Disease Market Size, Epidemiology, Industry Trends and Forecast 2024-2034"},"content":{"rendered":"
\"Coronary<\/a><\/div>\n
Coronary heart disease is a medical condition that develops when the arteries carrying blood to the heart muscle become narrowed or blocked.<\/div>\n

Market Overview:<\/strong><\/p>\n

Base Year: <\/strong>2023<\/p>\n

Historical Years: <\/strong>2018-2023<\/p>\n

Forecast Years: <\/strong>2024-2034<\/p>\n

Market Growth Rate:<\/strong> 5.17%<\/strong> (2024-2034)<\/p>\n

The coronary heart disease market is expected to exhibit a CAGR of 5.17% during 2024-2034<\/strong><\/a>. The coronary heart disease market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the coronary heart disease market.<\/p>\n

Request for a Sample Copy of this Report: <\/strong>https:\/\/www.imarcgroup.com\/coronary-heart-disease-market\/requestsample<\/a><\/p>\n

Coronary Heart Disease Market Trends:<\/strong><\/p>\n

Coronary heart disease is a medical condition that develops when the arteries carrying blood to the heart muscle become narrowed or blocked. The coronary heart disease market is experiencing substantial growth, driven by several key factors. Primarily, the market is expanding due to the rising prevalence of risk components, such as hypertension, diabetes, and obesity, which are closely linked to the onset of coronary heart disease. The aging population is also a significant contributor to market growth, as the risk of developing coronary heart disease increases with age. Moreover, advancements in medical technology, particularly in the areas of diagnostics and interventional cardiology, are playing a crucial role in the expansion of the coronary heart disease market. Additionally, the rising adoption of personalized medicine, which tailors treatment to individual patient profiles, is enhancing the effectiveness of CHD management.<\/p>\n

This trend is supported by increasing investments in research and development, leading to the introduction of innovative therapeutic options such as drug-eluting stents and novel anticoagulants. Furthermore, government initiatives aimed at promoting cardiovascular health through public awareness campaigns and improved healthcare infrastructure are contributing to the growth of the market. Consequently, the trend towards non-invasive diagnostic methods and the integration of artificial intelligence in coronary heart disease management are expected to drive the coronary heart disease market in the coming years, offering highly precise and effective treatment options.<\/p>\n

Countries Covered:<\/strong><\/p>\n

• United States<\/p>\n

• Germany<\/p>\n

• France<\/p>\n

• United Kingdom<\/p>\n

• Italy<\/p>\n

• Spain<\/p>\n

• Japan<\/p>\n

 <\/p>\n

Analysis Covered Across Each Country:<\/strong><\/p>\n

• Historical, current, and future epidemiology scenario<\/p>\n

• Historical, current, and future performance of the coronary heart disease market<\/p>\n

• Historical, current, and future performance of various therapeutic categories in the market<\/p>\n

• Sales of various drugs across the coronary heart disease market<\/p>\n

• Reimbursement scenario in the market<\/p>\n

• In-market and pipeline drugs<\/p>\n

 <\/p>\n

This report also provides a detailed analysis of the current coronary heart disease marketed drugs and late-stage pipeline drugs.<\/strong><\/p>\n

In-Market Drugs:<\/strong><\/p>\n

• Drug Overview<\/p>\n

• Mechanism of Action<\/p>\n

• Regulatory Status<\/p>\n

• Clinical Trial Results<\/p>\n

• Drug Uptake and Market Performance<\/p>\n

 <\/p>\n

Late-Stage Pipeline Drugs:<\/strong><\/p>\n

• Drug overview<\/p>\n

• Mechanism of action<\/p>\n

• Regulatory status<\/p>\n

• Clinical trial results<\/p>\n

• Drug uptake and market performance<\/p>\n

 <\/p>\n

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: <\/strong>https:\/\/www.imarcgroup.com\/request?type=report&id=8516&flag=C<\/a><\/p>\n

Competitive Landscape :<\/strong><\/p>\n

The competitive landscape of the coronary heart disease market has been studied in the report with the detailed profiles of the key players operating in the market.<\/p>\n

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.<\/p>\n

Browse Related Reports:<\/strong><\/p>\n

Low Back Pain Market Size, Share, Opportunity, Industry Trends, and Forecast 2024-2034<\/strong><\/a><\/p>\n

Metastatic Prostate Cancer Market Size, Share,  Trends, and Forecast 2024-2034<\/strong><\/a><\/p>\n

Metastatic Melanoma Market Size, Growth, Industry Trends, and Forecast 2024-2034<\/strong><\/a><\/p>\n

Breast Cancer Market Size, Overview, Research Report and Trends 2024-2034<\/strong><\/a><\/p>\n

Laminopathies Market Size, Epidemiology, Opportunity, Trends and Forecast 2024-2034<\/strong><\/a><\/p>\n

About Us<\/strong><\/p>\n

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.<\/p>\n

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> IMARC Group<\/a>
Contact Person:<\/strong> Elena Anderson
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1-631-791-1145
Address:<\/strong>134 N 4th St.
City:<\/strong> Brooklyn
State:<\/strong> NY
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.imarcgroup.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Coronary heart disease is a medical condition that develops when the arteries carrying blood to the heart muscle become narrowed or blocked. Market Overview: Base Year: 2023 Historical Years: 2018-2023 Forecast Years: 2024-2034 Market Growth Rate: 5.17% (2024-2034) The coronary heart disease market is expected … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,429],"tags":[],"class_list":["post-716072","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Hospitality"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/716072","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=716072"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/716072\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=716072"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=716072"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=716072"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}